Ignite Creation Date:
2024-05-06 @ 6:46 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05775523
Status:
RECRUITING
Last Update Posted:
2024-01-10
First Post:
2023-03-08
Brief Title:
A Post-Authorisation Safety Study PASS of Patients Treated With Lonapegsomatropin
Sponsor:
Ascendis Pharma Endocrinology Division AS
Organization:
Ascendis Pharma AS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Growth Hormone Deficiency |
Keywords:
| Name | View |
|---|---|
| SkyPASS | View |
| Human Growth Hormone | View |
| hGH | View |
| rhGH | View |
| GHD | View |
| Long Acting Growth Hormone | View |
| Lonapegsomatropin | View |
| Prodrug | View |
| Growth Failure | View |
| Growth Hormone Replacement Therapy | View |
| Sustained Release Growth Hormone | View |
| Growth Hormone Deficiency | View |
| TransCon hGH | View |
| Skytrofa | View |